Original language | English |
---|---|
Pages (from-to) | e489 |
Journal | The Lancet Oncology |
Volume | 23 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2022 |
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma
Tomer Meirson, Victoria Neiman, Michal Sternschuss, Gal Markel, Ian F. Tannock
Research output: Contribution to journal › Letter › peer-review
6
Scopus
citations